Juan Jesús
Cruz Hernández
Profesor Emérito
Publikationen, an denen er mitarbeitet Juan Jesús Cruz Hernández (31)
2024
-
Biología celular y molecular del cáncer
Oncología clínica (Arán Ediciones), pp. 13-23
2023
-
Telomere Length as a New Risk Marker of Early-Onset Colorectal Cancer
International Journal of Molecular Sciences, Vol. 24, Núm. 4
2022
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
2021
-
Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications
Biomolecules, Vol. 11, Núm. 2, pp. 1-16
-
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
Life, Vol. 11, Núm. 12
-
Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives
Applied Sciences (Switzerland), Vol. 11, Núm. 18
2020
-
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
Scientific Reports, Vol. 10, Núm. 1
2019
-
Genetic susceptibility in head and neck squamous cell carcinoma in a spanish population
Cancers, Vol. 11, Núm. 4
2017
-
Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
Scientific Reports, Vol. 7, Núm. 1
-
Biología Celular y Molecular del Cáncer
Oncología Clínica (Elsevier España), pp. 5-11
2016
2015
-
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
Genome Biology, Vol. 16, Núm. 1
2014
-
Analysis of DNA repair gene polymorphisms in glioblastoma
Gene, Vol. 536, Núm. 1, pp. 79-83
-
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers
Breast Cancer Research and Treatment, Vol. 148, Núm. 2, pp. 415-421
-
Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients
Clinical and Translational Oncology, Vol. 16, Núm. 2, pp. 158-165
2013
-
Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas
PLoS ONE, Vol. 8, Núm. 9
2011
-
Pacientes con criterios clínicos de síndrome de Lynch con y sin mutación en genes reparadores del ADN (MLH1 y MSH2). Un reto para el clínico
Medicina Clinica, Vol. 137, Núm. 4, pp. 166-170
2008
-
Medicina molecular: la medicina del siglo XXI
Real Academia de Medicina de Salamanca